(Q35115544)

6 August 2017

1 reference

title

New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy (English)

1 reference

6 August 2017

New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

28 December 2023

1 reference

0 references

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

28 December 2023

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

https://diabetesjournals.org/care/article-pdf/26/5/1589/592997/dc0503001589.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716823

https://diabetesjournals.org/care/article-pdf/26/5/1589/592997/dc0503001589.pdf

28 December 2023

file format

Portable Document Format

1 reference

Crossref

DOI

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

28 December 2023

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

1589-1596

1 reference

Diabetes and cardiovascular disease. The Framingham study

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Hyperglycemia and cardiovascular disease in type 2 diabetes

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Endothelial dysfunction in diabetes.

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Oxidative stress and diabetic vascular complications

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Free radicals mediate endothelial cell dysfunction caused by elevated glucose

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals.

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Hypertension and ascorbic acid

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Biochemistry and molecular cell biology of diabetic complications

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Enzymic mechanisms of superoxide production

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Nitric oxide synthases: Roles, tolls, and controls

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Mechanisms underlying endothelial dysfunction in diabetes mellitus

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Vascular targets of redox signalling in diabetes mellitus

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

High Glucose Increases Nitric Oxide Synthase Expression and Superoxide Anion Generation in Human Aortic Endothelial Cells

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Acute hyperglycemia induces an oxidative stress in healthy subjects

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Role of hyperglycemia in nitrotyrosine postprandial generation

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat.

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Nitrotyrosine causes selective vascular endothelial dysfunction and DNA damage

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Myocardial cell death in human diabetes

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation.

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Effects of insulin and antioxidant on plasma 8-hydroxyguanine and tissue 8-hydroxydeoxyguanosine in streptozotocin-induced diabetic rats

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Possible involvement of ADP-ribosylation of particular enzymes in cell death induced by nitric oxide-donors in human neuroblastoma cells

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Effects of the superoxide dismutase-mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart.

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

L-propionylcarnitine enhancement of substrate oxidation and mitochondrial respiration in the diabetic rat heart

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

L -propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Effects of propionyl-L-carnitine on isolated mitochondrial function in the reperfused diabetic rat heart

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Effects of acetyl- and proprionyl-l-carnitine on peripheral nerve function and vascular supply in experimental diabetes

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Molecular aspects of lipoic acid in the prevention of diabetes complications

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

PPAR gamma ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Are ACE inhibitors a "magic bullet" against oxidative stress?

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Hyperglycemia modulates angiotensinogen gene expression

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Angiotensin-receptor blockers, type 2 diabetes, and renoprotection

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.5.1589

28 December 2023

Identifiers

DOI

1 reference

6 August 2017

1 reference